Home Sulfos Thiophene-2-sulfonamide

Thiophene-2-sulfonamide

CAS No.:
6339-87-3
Catalog Number:
AG003HY1
Molecular Formula:
C4H5NO2S2
Molecular Weight:
163.2180
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
98%
In Stock USA
United States
$13
- +
5g
98%
In Stock USA
United States
$25
- +
25g
98%
In Stock USA
United States
$75
- +
100g
98%
In Stock USA
United States
$200
- +
Product Description
Catalog Number:
AG003HY1
Chemical Name:
Thiophene-2-sulfonamide
CAS Number:
6339-87-3
Molecular Formula:
C4H5NO2S2
Molecular Weight:
163.2180
MDL Number:
MFCD00185853
IUPAC Name:
thiophene-2-sulfonamide
InChI:
InChI=1S/C4H5NO2S2/c5-9(6,7)4-2-1-3-8-4/h1-3H,(H2,5,6,7)
InChI Key:
KTFDYVNEGTXQCV-UHFFFAOYSA-N
SMILES:
NS(=O)(=O)c1cccs1
NSC Number:
42521
RTECS Number:
XN0294000
Properties
Complexity:
181  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
162.976g/mol
Formal Charge:
0
Heavy Atom Count:
9  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
163.209g/mol
Monoisotopic Mass:
162.976g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
96.8A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-0.3  
Literature
Title Journal
Synthesis of novel tricyclic chromenone-based inhibitors of IRE-1 RNase activity. Journal of medicinal chemistry 20140522
The mechanism of γ-Secretase dysfunction in familial Alzheimer disease. The EMBO journal 20120516
Discovery and synthesis of hydronaphthoquinones as novel proteasome inhibitors. Journal of medicinal chemistry 20120308
BACE-1 inhibition prevents the γ-secretase inhibitor evoked Aβ rise in human neuroblastoma SH-SY5Y cells. Journal of biomedical science 20110101
Drug development for Alzheimer's disease: recent progress. Experimental neurobiology 20101201
Amyloid precursor protein selective gamma-secretase inhibitors for treatment of Alzheimer's disease. Alzheimer's research & therapy 20100101
Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease. The Journal of pharmacology and experimental therapeutics 20091101
Tryptamine-based human beta3-adrenergic receptor agonists. Part 1: SAR studies of the 7-position of the indole ring. Bioorganic & medicinal chemistry letters 20041220
Properties